UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Lancet neurology, ISSN 1474-4422, 2013, Volume 12, Issue 3, pp. 233 - 243
Neurology | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Severity of Illness Index | Double-Blind Method | Area Under Curve | Humans | Middle Aged | Immunoglobulins, Intravenous - adverse effects | Alzheimer Disease - drug therapy | Immunoglobulins, Intravenous - administration & dosage | Male | Amyloid beta-Peptides - blood | Alzheimer Disease - diagnosis | Dose-Response Relationship, Drug | Aged, 80 and over | Placebos | Female | Aged | Alzheimer Disease - immunology | Immunoglobulins, Intravenous - blood | Medical colleges | Immunoglobulins | Care and treatment | Neurosciences | Image processing | Analysis | Amyloid beta-protein | Clinical trials | Equipment and supplies | Alzheimer's disease | Index Medicus | Stroke | Intravenous administration | Neurodegenerative diseases | biomarkers | Cognitive ability | beta -Amyloid | Positron emission tomography | Drug | drug therapy | Intravenous | diagnosis | Alzheimer Disease | blood | 80 and over | administration & dosage | Amyloid beta-Peptides | adverse effects | Dose-Response Relationship | immunology | Neurovetenskaper
Journal Article
Lancet neurology, ISSN 1474-4422, 2013, Volume 12, Issue 8, pp. 822 - 838
Neurology | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Neuroimaging - methods | Guidelines as Topic | Humans | Cerebral Small Vessel Diseases - classification | Neurodegenerative Diseases - diagnosis | Terminology as Topic | Male | International Cooperation | Cerebral Small Vessel Diseases - complications | Neuroimaging - classification | Cerebral Small Vessel Diseases - diagnosis | Image Processing, Computer-Assisted | Aging | Female | Neuroimaging - standards | Medicine, Experimental | Medical research | Diagnostic imaging | Index Medicus | Position Paper | Neurologi | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 378, Issue 9805, pp. 1779 - 1787
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Neurology | Biological and medical sciences | General aspects | Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis | Medical sciences | Interferon-beta - administration & dosage | Antibodies, Monoclonal, Humanized - adverse effects | Multiple Sclerosis, Relapsing-Remitting - immunology | Double-Blind Method | Drug Administration Schedule | Multiple Sclerosis, Relapsing-Remitting - drug therapy | Humans | Gadolinium | Male | Multiple Sclerosis, Relapsing-Remitting - diagnosis | B-Lymphocytes - drug effects | Magnetic Resonance Imaging | Antibodies, Monoclonal, Humanized - administration & dosage | Contrast Media | Interferon-beta - adverse effects | Brain - pathology | Adult | Female | Infusions, Intravenous | Multiple sclerosis | Monoclonal antibodies | Physiological aspects | Research | Diagnosis | B cells | Drug therapy | Health aspects | Data collection | Medical research | Cytotoxicity | Clinical medicine | Index Medicus | Abridged Index Medicus
Journal Article
Annals of neurology, ISSN 0364-5134, 07/2020, Volume 88, Issue 1, pp. 93 - 105
Neurology | Clinical Neurology | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Confidence intervals | Atrophy | Neuroimaging | Brain | Multiple sclerosis | Magnetic resonance imaging | Aging | Biomarkers | Aging (natural) | Disease control | Age | Index Medicus
Journal Article
Lancet neurology, ISSN 1474-4422, 2016, Volume 15, Issue 3, pp. 292 - 303
Neurology | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Magnetic Resonance Imaging - methods | Multiple Sclerosis - diagnosis | Humans | Consensus | Practice Guidelines as Topic | Multiple sclerosis | Neurosciences | Diagnostic imaging | Diagnosis | Research institutes | Studies | Spinal cord | Funding | Compensation | Clinical trials | Pharmaceutical industry | Revisions | Index Medicus | Multiple Sclerosis | Magnetic Resonance Imaging | Criteria
Journal Article
Lancet neurology, ISSN 1474-4422, 2009, Volume 8, Issue 11, pp. 987 - 997
Neurology | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Disability Evaluation | Data Interpretation, Statistical | Double-Blind Method | Risk Assessment | Humans | Kaplan-Meier Estimate | Proportional Hazards Models | Male | Disease Progression | Interferon-beta - therapeutic use | Young Adult | Magnetic Resonance Imaging | Interferon beta-1b | Adult | Female | Surveys and Questionnaires | Multiple Sclerosis - drug therapy | Clinical trials | Multiple sclerosis | Universities and colleges | Drug therapy | Biological response modifiers | Interferon beta | Index Medicus
Journal Article
Lancet neurology, ISSN 1474-4422, 2008, Volume 7, Issue 7, pp. 615 - 625
Neurology | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Brain Mapping | Magnetic Resonance Imaging - methods | Magnetic Resonance Imaging - trends | Multiple Sclerosis - diagnosis | Humans | Medical colleges | Nuclear magnetic resonance spectroscopy | Multiple sclerosis | Magnetic resonance imaging | Metabolites | Index Medicus
Journal Article